Bisphenol A levels in bowel endometrioma diagnosed serums: A case control study

Basit Öğe Kaydı
dc.contributor.authorArdiç, Filiz
dc.contributor.authorÇelik, Humeyra
dc.contributor.authorYeşilyurt, Hüseyin
dc.contributor.authorOtçu, Serap Mutlu Özçelik
dc.date.accessioned2024-09-25T20:18:29Z
dc.date.available2024-09-25T20:18:29Z
dc.date.issued2022
dc.departmentAbant İzzet Baysal Üniversitesien_US
dc.description.abstractAim: To investigate the bisphenol A (BPA) levels, which may be a risk factor in the etiology of\rendometrioma, in patients diagnosed laparoscopically with endometrioma with and without bowel\rinvolvement.\rMethod: In the prospective cross-sectional case control study, 47 cases were included in the study, which were\radmitted to the gynecology and infertility services with and without bowel involvement endometrioma who\rwere operated and diagnosed histopathologically. 43 patients were included in the control group. For serum\rBPA value, blood samples taken immediately before the operation were studied in laboratory. Patients and\rcontrols were compared with controls in terms of serum BPA values.\rResults: The mean age of the patients was 35 ± 2 in the endometriosis group and 36 ± 2 in the control group\rwhich was and not statistically significant. There was no statistical difference between the patient and control\rgroups in terms of menstruation periods. Serum BPA levels were significantly higher in the bowel involvement\rgroup compared to the non-bowel involvement group, as the distribution width was higher due to excessive\rvalues, and only 5 patients with bowel involvement did not reach statistically significant levels. Serum BPA\rlevel was 1084±1132 ng/L in the endometriosis group and 269±99 ng/L in the control group which was\rstatistically significant (p<0,001).\rConclusions: BPA levels were showing very wide range especially in the patient group. Serum BPA levels\rwas statistically significantly higher in the endometrioma group compared to the control group. Therefore, in\rthe etiology of endometriosis BPA may take a definite place.en_US
dc.identifier.doi10.30714/j-ebr.2022173849
dc.identifier.endpage47en_US
dc.identifier.issn2618-6454
dc.identifier.issue1en_US
dc.identifier.startpage38en_US
dc.identifier.trdizinid523492en_US
dc.identifier.urihttps://doi.org/10.30714/j-ebr.2022173849
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/523492
dc.identifier.urihttps://hdl.handle.net/20.500.12491/15690
dc.identifier.volume5en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofExperimental Biomedical Researchen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzYK_20240925en_US
dc.titleBisphenol A levels in bowel endometrioma diagnosed serums: A case control studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu